Answer
Iressa (gefitinib) should not be used during pregnancy unless clearly necessary, because there are no data in pregnant women, animal studies show reproductive toxicity, and the potential human risk is unknown.
Sources for this answer
- Iressa 250mg film-coated tabletsAstraZeneca UK Limited · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 18Document updated
Sources checked